✦ LIBER ✦

399 Pharmacokinetics and Pharmacodynamics of TAK-733, an Investigational, Oral MEK Inhibitor, in Patients with Advanced Nonhematologic Malignancies

✍ Scribed by Zhou, X.; Faucette, S.; Kaun, S.; Gangolli, E.; Bozon, V.; Venkatakrishnan, K.

Book ID: 122877749
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 76 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72197-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

26 ORAL Phase Ib and pharmacodynamic stu

26 ORAL Phase Ib and pharmacodynamic study of the MEK inhibitor AZD6244 (ARRY-142886) in patients with advanced solid malignancies

✍ A. Adjei; R.B. Cohen; W.A. Franklin; J. Molina; S. Hariharan; E. Temmer; S. Brow 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

600 Pharmacokinetics and Pharmacodynamic

600 Pharmacokinetics and Pharmacodynamics of a Selective Oral MEK1/2 Inhibitor, Pimasertib (MSC1936369B/AS703026), in Patients with Advanced Solid Tumors

✍ Houédé, N.; Delord, J.P.; Awada, A.; Lebbe, C.; Lesimple, T.; Schellens, J.H.M.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase I clinical, pharmacokinetic and ph

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

✍ Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 308 KB

Phase I and pharmacokinetic/pharmacodyna

Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors

✍ Kazunori Honda, Noboru Yamamoto, Hiroshi Nokihara… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 242 KB

Phase I and pharmacokinetic study of cap

Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies

✍ Maarten J. Deenen, Heinz-Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Marie 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 299 KB

Phase I Expansion and Pharmacodynamic St

Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS-RAF Mutations

✍ Zimmer, L.; Barlesi, F.; Martinez-Garcia, M.; Dieras, V.; Schellens, J. H. M.; S 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 613 KB